People have confidence. some years ago Medpace researched all tracking products on the market and concluded bluechiip was the best and may be the future. Top 20 global pharma companies are not going to invest in a company that can't supply product. You can be sure they have done their due diligence before committing to changing their temperature and tracking operations. IMO the directors are pulling out all stops to maintain cash flow before a significant signing-FUJI. Some big investors recently sold out - hence share price down. More staff employed, more companies jumping on board, directors buying shares. Gotta keep the faith
People have confidence. some years ago Medpace researched all...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.092M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4005000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 3641582 | 9 |
View Market Depth
| Last trade - 10.11am 26/07/2024 (20 minute delay) ? |
| BCT (ASX) Chart |
Day chart unavailable